Sort
130,381 grants matching “hiv”
Tracking the evolutionary trajectory of neutralizing antibodies following BG505 SOSIP immunization
$1,590,054Cynthia Ann Derdeyn · University Of Washington · R01 · FY2025 · AI
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
$1,589,988Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2023 · DA
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies
$1,589,966Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2015 · AI
Eliciting B cells to produce anti-HIV gp41 MPER-specific neutralizing antibodies
$1,589,966Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2014 · AI
EXPANDED AND INTEGRATED HIV TESTING
$1,589,909Shannon L. Hader · District Of Columbia Dept Of Mental Hlth · U62 · FY2009 · PS
ADULT AIDS CLINICAL TRIALS UNIT
$1,589,759University Of Washington · U01 · FY2005 · AI
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
$1,589,707David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2022 · HL
Identifying and Engaging Urban HIV infected and uninfected YBMSM in care
$1,589,210David D. Celentano · Johns Hopkins University · R01 · FY2018 · DA
Clincial and Specimen Core
$1,588,845Susan Little · University Of California, San Diego · P01 · FY2009 · AI
HIV Persistence During Suppressive Antiretroviral Therapy
$1,588,506Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Vanderbilt HIV Clinical Trials Unit
$1,588,407Richard T D'aquila · Vanderbilt University · U01 · FY2011 · AI
Leaving, Coming, and Staying HIV Obligate Microenvironments (HOME)
$1,588,316David Mitchell Smith · University Of California, San Diego · P01 · FY2024 · AI
Capturing spatial patterns of new M. tuberculosis infection in Kampala, Uganda
$1,588,271Charles Martyn Bark · Case Western Reserve University · R01 · FY2019 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,588,110University Of Pittsburgh At Pittsburgh · U01 · FY2004 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,587,829Susan L Koletar · Ohio State University · U01 · FY2006 · AI
Modeling affinity maturation at molecular resolution
$1,587,693Thomas B Kepler · Boston University Medical Campus · U19 · FY2016 · AI
Gene Therapy Approaches for Primary Immunodeficiencies
$1,587,410Fabio Candotti · National Human Genome Research Institute · ZIA · FY2009 · HG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,586,279Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
PS09-962: SUPP. THE IMP. AND EXPANSION OF HIGH QUALITY HIV PREVENTION,CARE A
$1,586,170Dr. Anthony Amoroso · University Of Maryland Baltimore · U2G · FY2015 · PS
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
$1,585,769Michael Marcel Lederman · Case Western Reserve University · U19 · FY2008 · AI
CNS & Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,585,745Janice Ellen Clements · Johns Hopkins University · P01 · FY2011 · MH
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,585,664Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2015 · MH
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
$1,585,646Cynthia Ann Derdeyn · Emory University · R01 · FY2018 · AI
HIV-1 Vaccine Based on Chimp Serotypes of Adenovirus
$1,585,521Wistar Institute · P01 · FY2002 · AI
ENHANCED COMPREHENSIVE HIV PREVENTION PLANNING AND IMPLEMENTATION FOR METROPOLITA
$1,585,370Nanette Benbow · Chicago Department Of Public Health · U65 · FY2011 · PS